ArticleScientific reports2022

Sofosbuvir-based direct-acting antivirals and changes in cholesterol and low density lipoprotein-cholesterol.

Yi-Kai Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.